Stock Analysis on Net
Stock Analysis on Net
Microsoft Excel LibreOffice Calc

Vertex Pharmaceuticals Inc. (NASDAQ:VRTX)

Paying users zone. Data is hidden behind: .

  • Get 1-month access to Vertex Pharmaceuticals Inc. for $17.99, or

  • get full access to the entire website for at least 3 months from $49.99.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Verified by Visa MasterCard SecureCode American Express SafeKey

This is a one-time payment. There is no automatic renewal.

Statement of Comprehensive Income

Beginner level

Vertex Pharmaceuticals Inc., consolidated statement of comprehensive income

US$ in thousands

Microsoft Excel LibreOffice Calc
12 months ended: Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
Net income (loss)
Unrealized holding gains (losses) on marketable securities, net of tax
Unrealized gains (losses) on foreign currency forward contracts, net of tax
Foreign currency translation adjustment
Changes in other comprehensive income (loss)
Comprehensive income (loss)
Comprehensive (income) loss attributable to noncontrolling interest
Comprehensive income (loss) attributable to Vertex

Based on: 10-K (filing date: 2020-02-13), 10-K (filing date: 2019-02-13), 10-K (filing date: 2018-02-15), 10-K (filing date: 2017-02-23), 10-K (filing date: 2016-02-16).

Comprehensive income item Description The company
Net income (loss) attributable to Vertex The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Vertex Pharmaceuticals Inc.’s net income (loss) attributable to Vertex increased from 2017 to 2018 but then slightly decreased from 2018 to 2019 not reaching 2017 level.
Comprehensive income (loss) attributable to Vertex Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners. Vertex Pharmaceuticals Inc.’s comprehensive income (loss) attributable to Vertex increased from 2017 to 2018 but then slightly decreased from 2018 to 2019 not reaching 2017 level.